264 related articles for article (PubMed ID: 25519020)
41. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps.
Wu CW; Ng SS; Dong YJ; Ng SC; Leung WW; Lee CW; Wong YN; Chan FK; Yu J; Sung JJ
Gut; 2012 May; 61(5):739-45. PubMed ID: 21930727
[TBL] [Abstract][Full Text] [Related]
42. Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol.
Sun G; Cheng YW; Lai L; Huang TC; Wang J; Wu X; Wang Y; Huang Y; Wang J; Zhang K; Hu S; Yang JR; Yen Y
Oncotarget; 2016 Jan; 7(4):3857-72. PubMed ID: 26646696
[TBL] [Abstract][Full Text] [Related]
43. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
Duran-Sanchon S; Moreno L; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Martín A; Serradesanferm A; Pozo À; Costa R; Lacy A; Pellisé M; Lozano JJ; Gironella M; Castells A
Gastroenterology; 2020 Mar; 158(4):947-957.e4. PubMed ID: 31622624
[TBL] [Abstract][Full Text] [Related]
44. Identification of stool miR-135b-5p as a non-invasive diaognostic biomarker in later tumor stage of colorectal cancer.
Li L; Wang A; Cai M; Tong M; Chen F; Huang L
Life Sci; 2020 Nov; 260():118417. PubMed ID: 32931801
[TBL] [Abstract][Full Text] [Related]
45. miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome.
Ratert N; Meyer HA; Jung M; Lioudmer P; Mollenkopf HJ; Wagner I; Miller K; Kilic E; Erbersdobler A; Weikert S; Jung K
J Mol Diagn; 2013 Sep; 15(5):695-705. PubMed ID: 23945108
[TBL] [Abstract][Full Text] [Related]
46. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.
Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X
Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917
[TBL] [Abstract][Full Text] [Related]
47. RT-qPCR for Fecal Mature MicroRNA Quantification and Validation.
Ahmed FE; Ahmed NC; Gouda MM; Vos PW; Bonnerup C
Methods Mol Biol; 2018; 1765():203-215. PubMed ID: 29589310
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer.
Yau TO; Wu CW; Tang CM; Chen Y; Fang J; Dong Y; Liang Q; Ng SS; Chan FK; Sung JJ; Yu J
Oncotarget; 2016 Jan; 7(2):1559-68. PubMed ID: 26621842
[TBL] [Abstract][Full Text] [Related]
49. MicroRNAs expression profiling in Egyptian colorectal cancer patients.
Bader El Din NG; Ibrahim MK; El-Shenawy R; Salum GM; Farouk S; Zayed N; Khairy A; El Awady M
IUBMB Life; 2020 Feb; 72(2):275-284. PubMed ID: 31512372
[TBL] [Abstract][Full Text] [Related]
50. Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer.
Nonaka R; Miyake Y; Hata T; Kagawa Y; Kato T; Osawa H; Nishimura J; Ikenaga M; Murata K; Uemura M; Okuzaki D; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2015 Sep; 47(3):1097-102. PubMed ID: 26134152
[TBL] [Abstract][Full Text] [Related]
51. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
52. Fecal MicroRNAs as novel biomarkers for colon cancer screening.
Link A; Balaguer F; Shen Y; Nagasaka T; Lozano JJ; Boland CR; Goel A
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1766-74. PubMed ID: 20551304
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA Expression Levels and Histopathological Features of Colorectal Cancer.
Emami SS; Akbari A; Zare AA; Agah S; Masoodi M; Talebi A; Minaeian S; Fattahi A; Moghadamnia F
J Gastrointest Cancer; 2019 Jun; 50(2):276-284. PubMed ID: 29404790
[TBL] [Abstract][Full Text] [Related]
54. Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer.
Nonaka R; Nishimura J; Kagawa Y; Osawa H; Hasegawa J; Murata K; Okamura S; Ota H; Uemura M; Hata T; Takemasa I; Mizushima T; Okuzaki D; Yamamoto H; Doki Y; Mori M
Oncol Rep; 2014 Dec; 32(6):2354-8. PubMed ID: 25269744
[TBL] [Abstract][Full Text] [Related]
55. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.
Luo X; Stock C; Burwinkel B; Brenner H
PLoS One; 2013; 8(5):e62880. PubMed ID: 23690963
[TBL] [Abstract][Full Text] [Related]
56. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
57. MiR-216a-3p inhibits colorectal cancer cell proliferation through direct targeting COX-2 and ALOX5.
Wang D; Li Y; Zhang C; Li X; Yu J
J Cell Biochem; 2018 Feb; 119(2):1755-1766. PubMed ID: 28786533
[TBL] [Abstract][Full Text] [Related]
58. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B
Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150
[TBL] [Abstract][Full Text] [Related]
59. Clinical Potentials of miR-576-3p, miR-613, NDRG2 and YKL40 in Colorectal Cancer Patients.
Eldaly MN; Metwally FM; Shousha WG; El-Saiid AS; Ramadan SS
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1689-1695. PubMed ID: 32592365
[TBL] [Abstract][Full Text] [Related]
60. Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma.
Gao X; Wang Y; Zhao H; Wei F; Zhang X; Su Y; Wang C; Li H; Ren X
Oncotarget; 2016 Sep; 7(37):59664-59675. PubMed ID: 27517633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]